Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
2016 · Nature Communications · 178 citations
https://doi.org/10.1038/ncomms10787
P
Pablo Gallego
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
432
Citations
9
h-index
9
i10-index
Pablo Gallego is an academic researcher from AstraZeneca (Australia). The author has contributed to research in topics: Cellular transport and secretion & Monoclonal and Polyclonal Antibodies Research & Glycosylation and Glycoproteins Research. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0000-0002-9061-2507Papers by this author
worksThe IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds
2021 · Journal of Biological Chemistry · 38 citations
https://doi.org/10.1016/j.jbc.2021.100871
Structural Analysis of the Regulation of the DYNLL/LC8 Binding to Nek9 by Phosphorylation
2013 · Journal of Biological Chemistry · 31 citations
https://doi.org/10.1074/jbc.m113.459149
The intestinal MUC2 mucin C-terminus is stabilized by an extra disulfide bond in comparison to von Willebrand factor and other gel-forming mucins
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-37666-8
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library
2025 · SLAS DISCOVERY · 0 citations
https://doi.org/10.1016/j.slasd.2025.100216
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat